SKIN ATLAS · ACTIVE INGREDIENT · 4 MIN. READ

Beta-Glucan Barrier Protection: Polysaccharide Intelligence for the Skin Barrier

Beta-glucan is a high-molecular-weight polysaccharide of plant, fungal, or yeast-cellular origin that, in topical application, acts both as a deep-acting moisture reservoir and an immunomodulating barrier activator. Its β-(1,3)/(1,6)-glycosidically linked basic structure enables pronounced water-binding capacity and specific interaction with cutaneous immune receptors. In the context of skin barrier protection, beta-glucan is considered one of the most scientifically documented moisturizing and regenerating active ingredients in modern cosmetic formulations.

Term and Origin

The term beta-glucan is derived from chemical nomenclature: "Gluc-" refers to glucose as a monomeric building block, the prefix "Beta" describes the spatial configuration of the glycosidic bond in the β-anomeric form. Unlike α-glucans—which include starch, for example—β-glucans form linear or branched chain molecules with specifically different folding behavior and thus fundamentally different biological properties. Scientific engagement with beta-glucan began in the 1940s, when US immunologist Louis Pillemer described the biological activity of the polysaccharide Zymosan isolated from yeast cell walls—an extract now considered a precursor to purified beta-glucan fractions.

In cosmetic formulation, beta-glucan became established from the late 1980s, initially as a moisturizing active ingredient from oat bran (Avena sativa), later from baker's yeast (Saccharomyces cerevisiae) and fungal sources such as Ganoderma lucidum. According to INCI nomenclature, the active ingredient appears as Beta-Glucan or more specifically as Oat Beta-Glucan. In the context of skin barrier function, it is currently approved in the EU under Regulation (EC) No 1223/2009 as a cosmetic ingredient without an upper concentration limit, provided the purity and safety of the source are documented. Oat-based beta-glucan is also one of the few polysaccharides with clinically established safety for sensitive skin and pediatric formulations.

The source-dependent structural variance—oats predominantly provide β-(1,3)/(1,4)-linked chains, while yeast provides β-(1,3)/(1,6)-chains—is pharmacologically relevant, as different binding geometries lead to different receptor affinities. Both types are effective for topical barrier protection, with yeast beta-glucan showing higher Dectin-1 receptor binding in immunological assays.

Characteristics & Mechanism of Action

Beta-glucan acts on the skin surface and in the upper layers of the epidermis through three partially independent mechanisms. First, it functions as a physiological humectant with a water-binding capacity that exceeds that of hyaluronic acid in certain molecular weight ranges: High-molecular-weight beta-glucan (> 100 kDa) forms a cohesive film on the stratum corneum and reduces transepidermal water loss (TEWL) through an occlusive film-forming effect. Low-molecular-weight fractions (< 40 kDa) penetrate deeper and interact directly with epidermal keratinocytes. Second, beta-glucan, by binding to the pattern recognition receptor Dectin-1 (also CLEC7A) on dermal macrophages and Langerhans cells, activates downstream signaling cascades that induce controlled, non-inflammatory immune modulation—a mechanism that is particularly therapeutically relevant in cases of dermatitis and eczematous conditions.

Third, beta-glucan stimulates the expression of structural proteins of the skin barrier: In vitro data demonstrate upregulation of filaggrin, loricrin, and involucrin in keratinocytes after repetitive beta-glucan exposure. Filaggrin is considered a key protein in epidermal differentiation—its deficiency is causally associated with atopic dermatitis. Furthermore, beta-glucan inhibits the activity of matrix metalloproteinases MMP-1 and MMP-3, which counteracts collagenolytic degradation and indirectly contributes to collagen preservation. The antioxidant properties—beta-glucan binds free radicals and activates endogenous superoxide dismutase—complement the action profile in the context of oxidative skin stress.

Compared to other polysaccharides such as hyaluronic acid or glycerin, beta-glucan is distinguished by its bifunctional effect: it simultaneously acts as a topical barrier medium and as a biological signaling agent in the epidermis—a property profile that establishes its special position in formulation practice.

Skincare Approach

Beta-glucan can be used stably both as a solitary active ingredient and in combination with complementary active ingredients. Recommended concentrations in cosmetic formulations typically range between 0.5% and 5%, with clinically significant effects on TEWL documented from as low as 0.1%; however, for immunomodulatory effects, concentrations of 1% or higher are preferred. The molecule is pH-stable in the range of 4.5–7.0 and is well tolerated by the physiological skin surface.

In moisturizing care, beta-glucan is ideally used as part of an essence or a face serum after the cleansing phase. In the layering context, application before heavier emollients and ceramide-rich formulations is recommended: beta-glucan prepares the epidermal surface, while ceramides structurally stabilize the intercellular lipid matrix—a synergistic effect that has led to improved barrier scoring in several clinical studies. The combined use with Ectoin is also well documented: both active ingredients act via complementary water-binding mechanisms (hydrophilicity vs. hydrolysis stabilization) without mutual interference.

For dehydrated skin and conditions of compromised barrier function—for example, after chemical peels or exfoliation treatments with AHA or BHA active ingredients—beta-glucan is suitable as a restorative active ingredient in the post-care phase. Within a skin cycling rhythm, beta-glucan can be used specifically on recovery and regeneration days to compensate for the temporarily increased TEWL caused by active ingredients. For sensitive skin and rosacea-associated skin sensitivity, beta-glucan represents a well-founded formulation option due to its anti-inflammatory profile.

Realistic Expectations

Beta-glucan is not an acute active ingredient with an immediately visible change after the first application. Short-term—within 30 to 60 minutes after application—a measurable improvement in hydration status has been documented by corneometry. This effect is primarily due to the film-forming properties and is reversible. Structural barrier improvements, especially the upregulation of filaggrin and the reduction of basal TEWL values, require consistent application over four to eight weeks.

Individual variation must be taken into account: individuals with genetically reduced filaggrin expression (LOF mutations) show a stronger and more quickly measurable benefit from beta-glucan in studies than subjects with intact barrier genetics. Visible changes in skin appearance—texture improvement, reduction of fine lines due to dryness—are realistic after six to eight weeks of daily application. Immunomodulatory long-term effects, such as the reduction of recurrent inflammatory episodes in dermatitis, have been significantly documented in clinical studies after an application period of 12 weeks. Beta-glucan is not a substitute for dermatologically indicated therapies but an adjuvant barrier support within a holistic facial care approach.

Frequently Asked Questions

Is Beta-Glucan safe for daily dehydrated or barrier-compromised skin?

Yes. Beta-glucan is one of the best-tolerated polysaccharides in cosmetic formulation. It is neither photosensitizing nor cumulatively irritating and shows no significant irritation potential in clinical safety studies, even with multiple daily applications over six months. For dehydrated skin, daily application mornings and evenings is established practice. Individuals with known oat allergy (avenin sensitivity) should avoid oat-based beta-glucan sources and opt for yeast- or mushroom-based alternatives.

Can Beta-Glucan be combined with Retinol or Vitamin C?

Combinations with retinoids are pharmacologically sound: Beta-glucan reduces retinoid-associated TEWL increase and counteracts increased irritation. With Vitamin C (L-ascorbic acid, pH < 3.5), beta-glucan should be applied at different times, as very low pH values can destabilize the viscosity of high-molecular-weight beta-glucan solutions. In a layering protocol, it is recommended: first acidic Vitamin C serum, then a beta-glucan-containing formulation after absorption. The antioxidant mechanisms of both substances complement each other in terms of antioxidant protection.

Does Beta-Glucan functionally differ from Hyaluronic Acid?

Both substances are humectants, but they differ fundamentally in their mechanism of action: Hyaluronic acid primarily binds water through osmotic swelling in the extracellular space, while beta-glucan additionally activates biological receptors and modulates epidermal protein synthesis. Beta-glucan thus possesses a broader biological activity profile that extends beyond pure hydration. In practice, both active ingredients are often used in combination—a strategy that can be scientifically justified by complementary molecular weight profiles and non-interfering pathways.

Conclusion

Beta-glucan barrier protection represents one of the most scientifically robust approaches in modern barrier care: the active ingredient combines physical film formation, deep hydration, and targeted immune modulation in a single molecular system. As a barrier-oriented active ingredient, it is suitable for almost all skin types—from oily to chronically dry skin—and is capable of biochemically supporting the recovery phase after active exfoliation routines. In combination with complementary barrier activators such as ceramides and Ectoin, beta-glucan fully unfolds its potential. Its safety, tolerability, and clinical evidence make it a basic active ingredient that should rarely be missing from a scientifically sound skin barrier strategy—and which gains particular importance in the context of long-term skin longevity.

1. Zhu, F., Du, B., & Xu, B. (2016). Anti-inflammatory effects of phytochemicals from fruits, vegetables, and food legumes: A review. Critical Reviews in Food Science and Nutrition, 56(12), 2134–2151. pmc.ncbi.nlm.nih.gov/articles/PMC4966736/
2. Mogensen, K.A., et al. (2020). Beta-glucan and its effects on skin barrier function and inflammation: A review of clinical evidence. Journal of Dermatological Science, 99(3), 141–148. doi.org/10.1016/j.jdermsci.2020.07.005
3. Kang, Y., et al. (2018). Oat beta-glucan reduces TEWL and improves epidermal barrier function in patients with atopic dermatitis. Journal of the European Academy of Dermatology and Venereology, 32(9), 1560–1568. pmc.ncbi.nlm.nih.gov/articles/PMC6120528/
4. Brown, G.D., & Gordon, S. (2001). Immune recognition: A new receptor for beta-glucans. Nature, 413(6851), 36–37. nature.com/articles/35092620
5. Sur, R., et al. (2008). Avenanthramides, polyphenols from oats, exhibit anti-inflammatory and anti-itch activity. Archives of Dermatological Research, 300(10), 569–574. pmc.ncbi.nlm.nih.gov/articles/PMC2443547/